Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Annexon, Inc. (ANNX) Balance Sheet

As of 2026-06-30 (10-Q), Annexon, Inc. (ANNX) reported total assets of $246.1M, total liabilities of $60.0M and shareholders' equity of $186.1M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $199.3M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ANNXAnnexon, Inc.Follow ANNX — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
766.7M
P/E TTM
—
Dividend yield
0.0%
52-week
—
Next earnings
16 Nov, in 23 days
LineFY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Jun 26
Trend
Cash and equivalents268.674.8140.0225.149.5162.1199.3
Short-term investments82.6167.9102.634.6262.576.310.0
Current assets354.0247.7248.1263.9316.5242.2212.8
Total assets355.9287.0285.1297.7350.1277.6246.1
Current liabilities10.621.722.417.930.542.638.5
Total liabilities11.755.153.947.157.065.960.0
Shareholders' equity344.3231.9231.2250.6293.1211.6186.1

USD millions · SEC XBRL

Annexon, Inc. — questions

How much cash does Annexon, Inc. have?
$199.3M in cash and cash equivalents as of 2026-06-30.
What are Annexon, Inc.'s total assets?
$246.1M as of 2026-06-30.
What is Annexon, Inc.'s shareholders' equity?
$186.1M as of 2026-06-30.

Every figure on this page comes from Annexon, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.